İçerikte Neler Var?

Top 11 Trends in Healthcare to watch for 2022 and beyond

by Yavuz S. Silay , MD , MBA

1) Metaverse Healthcare applications on the Rise in Surgery, Radiology, Dermatology, Pathology, Molecular Biology & Genetics while ethical aspects will continue to be a key discussion

2) 2022 will be ” Digital Healthcare Startup & Scaleup Year” due to the effect of Pandemy generated a significant increase on the investments for digital healthcare startups & scaleups globally

3) Increased awareness of Remote Healthcare app options for patients such as https://www.clicktherapeutics.com/ using Software as a therapeutic solution and delivering safe and effective digital treatments to patients in need will become more popular

4) Preventive, outcome based pharmacoeconomic models will continue to enhance access and will be as important as Quality & Affordability for Payers

5) 2D models until Metaverse kicks in such as some of the AR/VR apps will continue to be entegrating & enhancing Healthcare Educational & Treatment modalities across healthcare systems around the globe

6) Annuity based model is expected to enhance Gene-Therapy Commercialization

7) 2022 will be the year of continued VC Megarounds for Digital Healthcare Unicorns & Gazelles with IPO Exits

8) Telemedicine / Telehealth will continue to rapidly rise and start to become mainstream in healthcare for certain global markets

9) Precision Medicine / Personalized therapies will continue to expand while getting more affordable with current & new indications & access to more patients globally expected

10) Health Data Analytics Solutions will gain traction specifically for orphan diseases and utilization of health data analytics for precision medicine is going to rise

11) 2022 is the new era of Prescription software applications as medical devices that work with pharmacotherapies or independently to treat diseases . Therefore, Software as a Medical Device ( SaMD) focusing on biotechnology companies developing applications as medical treatments in accordance with all regulations such as FDA, EMA, SFDS ( Chinese FDA) , Turkish Medicine & Medical Device Agencies, ISO & IEC standarts will grow exponentially in the global market

Yavuz Selim Sılay

Web Sitesi

*20 Inspiring Facts from Dr Yavuz Selim Sılay's Biography*

Yavuz Selim Sılay is a Physician Entrepreneur , certified clinical research professional society, Clinical Research Associate (CCRP) in 2004, recipient of Young Investigator Award at Baylor College of Medicine as fellow in 2001-2003

Yavuz was born in İstanbul. Lived during his childhood 7 years in Germany. Started his career and continued 14 years in USA, now lives since 2013 in Ankara , Turkey

Started his elementary school in Germany and completed in 2 countries 4 cities. Graduated from his primary education in Mithatpasa, Ilkokulu , Iskenderun, Hatay

Dr Yavuz signed off high school in 1993 at Iskenderun Anatolian Anatolian High School

Dr. Silay became a medical doctor after graduating from the Faculty of Medicine, University of Ankara in 2000

Dr Yavuz Selim Sılay completed his clinical internship at Baylor college of medicine, Houston Texas.

Dr Yavuz Selim Sılay is married to Dr Kamile Sılay, An award winning medical scholar since 1997.

Dr Yavuz Selim has 3 beautiful kids , 2 girls and one boy

Dr Yavuz speaks multiple languages including English, German, Arabic & Turkish

Dr Yavuz Selim is a sportsman and have been selected into the Turkish Badminton Federation Health committee

Yavuz Selim is the managing partner of a television and radio network NTR TV broadcasting to 900 million in 42 countries via satellite in English and French and executive director of Tivi6 a Private National TV broadcasting to 84 million in Turkey

Dr. Silay previously managed Siemens healthcare's one of the largest distributor with 220 employees in Turkey.

Founded ICG ( İstanbul Consulting Group) in 2013 and Co-founded BioCube Istanbul a Bioentrepreneurship & Innovation Center in 2018.

Dr Silay Yavuz was the VP of IPSEN pharmaceutical & Director of TEVA pharmaceuticals & Associate Director of KV Pharmaceutical and Clinical Research Physician at Forest Pharmaceutical

Dr Silay was a former AIFD Director for Market Access and Health policy in Turkey.

Dr. Sılay is active as a the board member of many NGO's such as WIHU ( World Islamic Health Union) ( http://www.wihu.org.tr/en/ ) , Sağlık- der( https://www.saglikder.org.tr ) , SADEFE ( https://www.sadefe.org )
and chartered the Turkey Chapter of SoPE ( Society of Physician Entrepreneur) in Turkey. (https://sopenet.org/chapter/turkey/ ) a Non-Profit global Biomedical & Healthcare Innovation Network based in Colorado, USA.

Dr Silay’s numerous research works are available in both Turkey, USA and global medical journals and libraries. He has 18 peer reviewed articles at pubmed and more than 200 abstracts & oral presentations around the world

Dr Silay is a pioneer in Halal Finance, Venture Capitalist and an Angel investor.Dr Yavuz Selim is a co-founder of MaQasid Angel Investment Network (MAIN) which is the first Interest Free Angel Investors Network in Turkey

Dr. Yavuz Selim Sılay is the co-founder of Ral Kitle Fonlama Platformu, Fonkolay , a crowdfunding platform newly established in 2021.

Interests are in Halal Finance , Health, Pharmaceutical, Bioentrepreneurship, MENA region technology innovations and as a venture architect launching viable Startups pose to become Scaleups

Among many investments one of them is PRP Pharmaceuticals, one of the startup companies within IAU BioCube Istanbul, received a seed investment from MAIN (Maqasid Angel Investment Network) with a valuation of 5 million TL.